Viral Manipulation of Myeloid Cell Function

病毒操纵骨髓细胞功能

基本信息

项目摘要

DESCRIPTION (provided by applicant): The innate immune system responds rapidly to virus infection and aims to contain a virus infection in the periphery prior to the initiation of an adaptive immune response that can clear the infection. However, an unintended consequence of innate immune activity is potentially dangerous tissue damage mediated by the cells of the innate response that the proinflammatory mediators that they produce. To prevent or reduce tissue damage an infected host will initiate a number of strategies to reduce the inflammation induced upon innate immune activation, including the downregulation of the innate and adaptive immune systems and the initiation of tissue protective or "pro-resolving" strategies. Such strategies represent and attractive target for viruses to manipulate to reduce immune activity directed against a virus and to preserve tissue integrity to allow enhanced virus replication. One mechanism used to downregulate the immune response and promote tissue integrity by the host is the production of glucocorticoids. A number of viruses, including influenza and vaccinia (VACV), the virus used here, promote the production of glucocorticoids upon infection. VACV induces glucocorticoid production by expression of the A44L gene product, and deletion of this gene attenuates the virus in vivo and results in a reduction of tissue damage in the skin. However, the mechanisms by which A44L mediates these effects are unknown and are the focus of this application. In Aim 1 we will investigate the effect of A44L-derived glucocorticoids on infiltration of different populations of myeloid cells, including a recently identified population of pro-resolving myeloid cells during VACV infection, and the function (production of cytokines and reactive oxygen species) of these myeloid populations. In Aim 2 we will examine the effects of A44L-derived GC upon dendritic cell heterogeneity, numbers, infiltration, migration, antigen presentation and cytokine production, as our previous results indicate that an effect of GC upon dendritic cells is responsible for a reduction in T cell responsiveness. In both Aim 1 and 2 we will identify the target cell directly affected by A44L-derived glucocorticoids to modulate the immune response. At the conclusion of these studies we will have gained a deeper understanding of the mechanisms that VACV and other viruses deploy to prevent or slow the immune response and preserve tissue integrity, as well as the mechanisms of action of GC upon various components of the innate and adaptive immune response.
描述(由申请人提供):先天免疫系统对病毒感染反应迅速,目的是在启动可清除感染的适应性免疫应答之前将病毒感染控制在外周。然而,先天免疫活动的一个意想不到的后果是由它们产生的促炎介质的先天反应细胞介导的潜在危险的组织损伤。为了防止或减少组织损伤,受感染的宿主会启动许多策略来减少先天免疫激活引起的炎症,包括下调先天和适应性免疫系统以及启动组织保护或“促解决”策略。这些策略为病毒提供了一个有吸引力的靶标,可以用来降低针对病毒的免疫活性,并保持组织的完整性,从而增强病毒的复制。宿主下调免疫反应和促进组织完整性的一种机制是糖皮质激素的产生。许多病毒,包括流感病毒和牛痘病毒(这里使用的病毒),在感染时促进糖皮质激素的产生。VACV通过表达A44L基因产物诱导糖皮质激素的产生,该基因的缺失在体内减弱病毒并导致皮肤组织损伤的减少。然而,A44L介导这些作用的机制是未知的,也是本应用的重点。在Aim 1中,我们将研究a44l衍生的糖皮质激素对不同髓系细胞群浸润的影响,包括最近发现的在VACV感染期间的促溶解髓系细胞群,以及这些髓系细胞群的功能(细胞因子和活性氧的产生)。在Aim 2中,我们将研究a44l衍生的GC对树突状细胞异质性、数量、浸润、迁移、抗原呈递和细胞因子产生的影响,因为我们之前的结果表明,GC对树突状细胞的影响是T细胞反应性降低的原因。在Aim 1和Aim 2中,我们将确定受a44l衍生糖皮质激素直接影响的靶细胞,以调节免疫反应。在这些研究的结论中,我们将更深入地了解VACV和其他病毒用于预防或减缓免疫反应和保持组织完整性的机制,以及GC对先天和适应性免疫反应的各种组成部分的作用机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher C Norbury其他文献

Christopher C Norbury的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher C Norbury', 18)}}的其他基金

How does Cytomegalovirus use interferon lambda for optimal spread
巨细胞病毒如何利用 lambda 干扰素实现最佳传播
  • 批准号:
    10552002
  • 财政年份:
    2022
  • 资助金额:
    $ 22.95万
  • 项目类别:
The effect of local virus infection upon cutaneous wound healing: the impact of virus-induced Type III IFNs
局部病毒感染对皮肤伤口愈合的影响:病毒诱导的III型干扰素的影响
  • 批准号:
    10433972
  • 财政年份:
    2021
  • 资助金额:
    $ 22.95万
  • 项目类别:
The effect of local virus infection upon cutaneous wound healing: the impact of virus-induced Type III IFNs
局部病毒感染对皮肤伤口愈合的影响:病毒诱导的III型干扰素的影响
  • 批准号:
    10217681
  • 财政年份:
    2021
  • 资助金额:
    $ 22.95万
  • 项目类别:
Interferon-independent STAT1-mediated protective antiviral immunity
不依赖干扰素的STAT1介导的保护性抗病毒免疫
  • 批准号:
    9378819
  • 财政年份:
    2017
  • 资助金额:
    $ 22.95万
  • 项目类别:
Analysis of the mechanism of HCMV cytoplasmic envelopment
HCMV胞质包膜机制分析
  • 批准号:
    10659275
  • 财政年份:
    2017
  • 资助金额:
    $ 22.95万
  • 项目类别:
The Toponome of Virus Infected Skin
病毒感染皮肤的地形图
  • 批准号:
    9186754
  • 财政年份:
    2016
  • 资助金额:
    $ 22.95万
  • 项目类别:
Poxviruses and Pro-Resolving Lipids
痘病毒和促溶解脂质
  • 批准号:
    8808629
  • 财政年份:
    2014
  • 资助金额:
    $ 22.95万
  • 项目类别:
Viral Manipulation of Myeloid Cell Function
病毒操纵骨髓细胞功能
  • 批准号:
    8226379
  • 财政年份:
    2012
  • 资助金额:
    $ 22.95万
  • 项目类别:
Histology and Imaging Core
组织学和成像核心
  • 批准号:
    7746214
  • 财政年份:
    2009
  • 资助金额:
    $ 22.95万
  • 项目类别:
Processing & Presentation of Ectromelia Virus to CD4+ T Lymphocytes - Asso Projec
加工
  • 批准号:
    7982871
  • 财政年份:
    2009
  • 资助金额:
    $ 22.95万
  • 项目类别:

相似海外基金

Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy - Supplement
定义实验性 AD 和 Tau 病中 MHC I 类限制性抗原呈递至 CD8 T 细胞 - 补充
  • 批准号:
    10836880
  • 财政年份:
    2023
  • 资助金额:
    $ 22.95万
  • 项目类别:
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
靶向 MAL2 介导的内吞作用以增强肿瘤细胞抗原呈递
  • 批准号:
    10734324
  • 财政年份:
    2023
  • 资助金额:
    $ 22.95万
  • 项目类别:
Antigen presentation to the adaptive immune system in the choroid contributes to ocular autoimmune disease
脉络膜中的适应性免疫系统的抗原呈递导致眼部自身免疫性疾病
  • 批准号:
    10740465
  • 财政年份:
    2023
  • 资助金额:
    $ 22.95万
  • 项目类别:
Investigation of Target Protein Degradation and Its Effect on Enhancing Cancer-Specific Antigen Presentation by Quantitative Mass Spectrometry
通过定量质谱研究靶蛋白降解及其对增强癌症特异性抗原呈递的影响
  • 批准号:
    23K04971
  • 财政年份:
    2023
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Promoting cancer cells' antigen presentation for serving as better targets for T cell immunotherapy
促进癌细胞的抗原呈递,作为 T 细胞免疫治疗的更好靶点
  • 批准号:
    2885451
  • 财政年份:
    2023
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Studentship
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
结直肠癌免疫治疗中靶向免疫蛋白酶体介导的抗原呈递
  • 批准号:
    10385926
  • 财政年份:
    2022
  • 资助金额:
    $ 22.95万
  • 项目类别:
Lipid Antigen Presentation as a Driver of T2D Inflammation
脂质抗原呈递作为 T2D 炎症的驱动因素
  • 批准号:
    10509043
  • 财政年份:
    2022
  • 资助金额:
    $ 22.95万
  • 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
  • 批准号:
    10704008
  • 财政年份:
    2022
  • 资助金额:
    $ 22.95万
  • 项目类别:
Sex Differences in lipid antigen presentation, impact of lipid antigen presentation on peripheral lipid metabolism
脂质抗原呈递的性别差异,脂质抗原呈递对外周脂质代谢的影响
  • 批准号:
    10818273
  • 财政年份:
    2022
  • 资助金额:
    $ 22.95万
  • 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
  • 批准号:
    10349397
  • 财政年份:
    2022
  • 资助金额:
    $ 22.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了